FdaApplication
BLA 125513
Identifiers
- fda_app_no: BLA125513
Properties
| Property | Value |
|---|---|
| applicant_name | Alexion Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2015-10-23 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| STRENSIQ | ASFOTASE ALFA | 28MG/0.7ML | Injection |
| STRENSIQ | ASFOTASE ALFA | 80MG/0.8ML | Injection |
| STRENSIQ | ASFOTASE ALFA | 18MG/0.45ML | Injection |
| STRENSIQ | ASFOTASE ALFA | 40MG/ML | Injection |
4 products